Role of Chyawanprash in the prevention of COVID-19 in health care workers
Phase 3
Completed
- Registration Number
- CTRI/2020/05/025275
- Lead Sponsor
- CCRAS New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 199
Inclusion Criteria
1) All healthcare professionals and staff of age group between 25 to 60 years willing to participate, negative for SARS- Cov-2 at screening,(tested by rt-PCR) without co-morbid condition
Exclusion Criteria
1) Pregnant and lactating females.
2) Immune compromised and co morbid condition cases.
3)Laboratory confirmed COVID-19 with or without symptoms
4)Known allergy to any of the medications used in this trial.
5) Subjects who are taking any other medicine as prophylaxis such as HCQ.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of participants with SARS- Cov-2 positivity as estimated by RT-PCR of nasopharyngeal swabTimepoint: baseline <br/ ><br>Day 30
- Secondary Outcome Measures
Name Time Method Safety profile of the intervention as estimated by LFT, KFT and other haematological & biochemical investigations. <br/ ><br>Presence or absence of AE/ADR. <br/ ><br>Number of participants who developed any infective diseases during the trial period (bacterial /viral/ fungal / etc.) and percentage of participants with Upper respiratory tract illness during the period. <br/ ><br>Timepoint: baseline <br/ ><br>Day 7 <br/ ><br>Day 15 <br/ ><br>Day 30